Anxo Fernandez-Ferreiro
Overview
Explore the profile of Anxo Fernandez-Ferreiro including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
86
Citations
659
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Toja-Camba F, Vidal-Millares M, Duran-Maseda M, Arrojo-Romero M, Puente-Iglesias M, Hermelo-Vidal G, et al.
Biomedicines
. 2025 Feb;
13(2).
PMID: 40002797
: Risperidone ISM is a long-acting injectable (LAI) formulation approved for monthly administration in schizophrenia treatment. It employs innovative in situ microimplant technology for biphasic drug release, achieving immediate and...
2.
Toja-Camba F, Vidal-Millares M, Duran-Maseda M, Hermelo-Vidal G, Carracedo A, Maronas O, et al.
Sci Rep
. 2025 Jan;
15(1):1521.
PMID: 39789135
Aripiprazole (ARI) is an atypical antipsychotic which is a substrate of P-glycoprotein (P-gp), a transmembrane glycoprotein that plays a crucial role in eliminating potentially harmful compounds from the organism. ARI...
3.
Varela-Rey I, Bandin-Vilar E, Toja-Camba F, Canizo-Outeirino A, Cajade-Pascual F, Ortega-Hortas M, et al.
Antibiotics (Basel)
. 2025 Jan;
13(12).
PMID: 39766593
The use of artificial intelligence (AI) and, in particular, machine learning (ML) techniques is growing rapidly in the healthcare field. Their application in pharmacokinetics is of potential interest due to...
4.
Codesido J, Garcia-Varela L, Garcia-Otero X, Bouzon-Barreiro S, Gomez-Lado N, Toja-Camba F, et al.
Int J Pharm
. 2024 Dec;
669():125011.
PMID: 39617190
Monoclonal antibodies targeting tumor necrosis factor-alpha (antiTNF-α) are used for patients with immuno-mediated illness as inflammatory bowel disease (IBD). However, 20-40 % of IBD patients do not respond to these...
5.
Toja-Camba F, Hermelo-Vidal G, Feitosa-Medeiros C, Vidal-Millares M, Duran-Maseda M, Fernandez-Ferreiro A, et al.
Pharmaceuticals (Basel)
. 2024 Nov;
17(11).
PMID: 39598358
Risperidone, a second-generation antipsychotic widely used in the treatment of schizophrenia, requires therapeutic drug monitoring due to its high interindividual variability. UHPLC-MS/MS is considered the gold standard for pharmacokinetic studies...
6.
Rodriguez-Martinez L, Rodriguez-Fernandez C, Rodriguez Lemos O, de Domingo B, Garcia Bru P, Mateos J, et al.
Invest Ophthalmol Vis Sci
. 2024 Nov;
65(13):29.
PMID: 39540857
Purpose: Adalimumab (ADA) is a systemic biological treatment option approved for the treatment of noninfectious uveitis (NIU); however, up to 40% of patients do not respond to the drug, either...
7.
Ortea I, Rodriguez-Martinez L, Carrera M, Fafian-Labora J, Arufe M, Gonzalez-Barcia M, et al.
Biomed Pharmacother
. 2024 Nov;
181:117650.
PMID: 39504626
Cysteamine, an aminothiol, is the only available treatment for cystinosis, an incurable metabolic recessive disease characterized by detrimental symptoms at the renal, ocular, and muscular levels. Cystinosis is due to...
8.
Bandin-Vilar E, Estany-Gestal A, Cabaleiro T, Rial-Pensado E, Castro-Balado A, Varela-Rey I, et al.
BMJ Open
. 2024 Oct;
14(10):e087465.
PMID: 39477268
Introduction: Linezolid is a broadly used antibiotic to treat complicated infections caused by gram-positive bacteria. Therapeutic drug monitoring of linezolid concentrations is recommended to maximise its efficacy and safety, mainly...
9.
Rey-Bretal D, Garcia-Varela L, Gomez-Lado N, Moscoso A, Pineiro-Fiel M, Diaz-Platas L, et al.
Neuroimage
. 2024 Sep;
300:120873.
PMID: 39341474
Introduction SUV measurements from static brain [F]FDG PET acquisitions are a commonly used tool in preclinical research, providing a simple alternative for kinetic modelling, which requires complex and time-consuming dynamic...
10.
Puente-Iglesias M, Cuartero-Martinez A, Tourino-Peralba R, Rodriguez-Ares M, Giraldez M, Yebra-Pimentel E, et al.
Int J Mol Sci
. 2024 Sep;
25(18).
PMID: 39337336
Ophthalmic tacrolimus compounded formulations are usually made from the commercial intravenous presentation, which contains ethanol as a solubilizer due to the low solubility of tacrolimus. The use of cyclodextrins is...